Quantcast

Latest Retina Stories

2014-08-21 23:08:58

Transparency Market Research published a new report "Fundus Cameras Market: Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2019" to its report store. (PRWEB) August 21, 2014 According to a new market report published by Transparency Market Research "Fundus Cameras Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the global fundus cameras market was valued at USD 236.1 million in 2011 and is...

2014-08-21 04:21:27

LAUSANNE, Switzerland, August 21, 2014 /PRNewswire/ -- 36 blind patients with retinitis pigmentosa will receive groundbreaking Argus II 'bionic eye' treatment starting in September Second Sight Medical Products Inc. (Second Sight) today announces that the French Ministry of Health has officially approved financial support for the Argus II Retinal Prosthesis System. Through the Forfait Innovation scheme, the French Government will pay for the first wave of groundbreaking...

2014-08-12 08:39:29

Mobile Spy Takes Online Safety and Security for Children and Businesses to the New Level JACKSONVILLE, Fla., Aug. 12, 2014 /PRNewswire/ -- Mobile Spy, the most advanced monitoring software for mobile devices, announced today the launch of Mobile Spy Version 7.0. The newest and most innovative version of the software now makes it easier than ever for parents to protect their children and for employers to safeguard their companies. http://photos.prnewswire.com/prnvar/20140811/135102...

2014-08-11 04:21:59

Potentially Life-Changing Subretinal Implant Now Available at Six Leading Eye Clinics Across Germany REUTLINGEN, Germany, Aug. 11, 2014 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that the Company's Alpha IMS microchip was granted NUB innovation status and will now be reimbursed by Germany's statutory health insurance system. Insuring 90 percent of the country's citizens, the German...

2014-08-07 23:04:10

Global Retinal Vein Occlusion Market 2014-2018 analyzes key players like Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG and Regeneron Pharmaceuticals Inc., Alimera Sciences, Bristol-Myers Squibb, NicOx, Santen Pharmaceutical and Valeant Pharmaceuticals. Dallas, Texas (PRWEB) August 07, 2014 One of the growth-pertaining trends in the market is the introduction of biologics as a treatment option for retinal vein occlusion. Drugs such as Avastin (bevacizumab) and Lucentis (ranibizumab),...

2014-08-04 09:09:20

University of Iowa University of Iowa researchers create most detailed molecular map of eye region associated with vision loss Understanding eye diseases is tricky enough. Knowing what causes them at the molecular level is even more confounding. Now, University of Iowa researchers have created the most detailed map to date of a region of the human eye long associated with blinding diseases, such as age-related macular degeneration. The high-resolution molecular map catalogs...

2014-07-30 23:04:02

On Sunday, September 28th Foundation Fighting Blindness will choose the new owner of a 2014 Limited Edition SRT Dodge Viper in the name of retina research. Nanuet, NY (PRWEB) July 30, 2014 On Sunday, September 28th Foundation Fighting Blindness will choose the new owner of a 2014 Limited Edition SRT Dodge Viper in the name of retina research. The Foundation Fighting Blindness (FFB) has been raising awareness since 1971. The foundation has over 50 volunteer groups across the United States...

2014-07-14 23:03:57

The Retina Group of New York (RGONY), with offices in Hicksville and Hauppauge, NY, has announced the availability of Ozurdex® (dexamethasone intravitreal implant) as a long-lasting treatment for diabetic macular edema (DME) patients. Hicksville and Hauppauge, NY (PRWEB) July 14, 2014 The Retina Group of New York (RGONY), with offices in Hicksville and Hauppauge, NY, has announced the availability of Ozurdex® (dexamethasone intravitreal implant) as a long-lasting treatment for...

Researcher Reveals Novel Treatment For A Form Of Childhood Blindness
2014-07-14 03:18:37

McGill University Health Centre An international research project, led by the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, reports that a new oral medication is showing significant progress in restoring vision to patients with Leber congenital amaurosis (LCA). Until now, this inherited retinal disease that causes visual impairment ranging from reduced vision to complete blindness, has remained untreatable. The study is published today in the scientific...

2014-07-14 12:20:58

Cedars-Sinai Medical Center Preliminary results show the device, created at Cedars-Sinai and developed by NeuroVision Imaging, may provide highly predictive early detection of changes associated with Alzheimer's disease A noninvasive optical imaging device developed at Cedars-Sinai can provide early detection of changes that later occur in the brain and are a classic sign of Alzheimer's disease, according to preliminary results from investigators conducting a clinical trial in...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related